APO Research

APO RESEARCH · REPORT

Probiotics for Middle-aged and Elderly

Selected research

Market Structure

Global Probiotics for Middle-aged and Elderly Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Probiotics for Middle-aged and Elderly market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Probiotics for Middle-aged and Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Probiotics for Middle-aged and Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Probiotics for Middle-aged and Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Probiotics for Middle-aged and Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Probiotics for Middle-aged and Elderly include DuPont(Danisco), Chr. Hansen, China-Biotics, Nestle, Danone, BioGaia, OMNi-BiOTiC, Glory Biotech and Ganeden, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Probiotics for Middle-aged and Elderly market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Probiotics for Middle-aged and Elderly and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Probiotics for Middle-aged and Elderly sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Probiotics for Middle-aged and Elderly market size, projected growth trends, production technologies, key applications, and end-use industries.

Probiotics for Middle-aged and Elderly Segment by Company

DuPont(Danisco)

Chr. Hansen

China-Biotics

Nestle

Danone

BioGaia

OMNi-BiOTiC

Glory Biotech

Ganeden

Morinaga Milk Industry

Sabinsa

Greentech

Bioriginal

Biosearch Life

UAS Laboratories

Synbiotech

Probiotics for Middle-aged and Elderly Segment by Type

Lactic Acid Bacteria

Bifidobacterium

Others

Probiotics for Middle-aged and Elderly Segment by Application

Supermarket

Online Retail

Others

Probiotics for Middle-aged and Elderly Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Probiotics for Middle-aged and Elderly market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Probiotics for Middle-aged and Elderly and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Probiotics for Middle-aged and Elderly.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Probiotics for Middle-aged and Elderly market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Probiotics for Middle-aged and Elderly manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Probiotics for Middle-aged and Elderly in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Probiotics for Middle-aged and Elderly in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Probiotics for Middle-aged and Elderly Industry Trends Table 2. Probiotics for Middle-aged and Elderly Industry Drivers Table 3. Probiotics for Middle-aged and Elderly Industry Opportunities and Challenges Table 4. Probiotics for Middle-aged and Elderly Industry Restraints Table 5. Global Probiotics for Middle-aged and Elderly Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Probiotics for Middle-aged and Elderly Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Probiotics for Middle-aged and Elderly Sales Market Share by Manufacturers Table 9. Global Probiotics for Middle-aged and Elderly Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Probiotics for Middle-aged and Elderly Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Probiotics for Middle-aged and Elderly Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Probiotics for Middle-aged and Elderly Manufacturers, Product Type & Application Table 13. Global Probiotics for Middle-aged and Elderly Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Probiotics for Middle-aged and Elderly by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Lactic Acid Bacteria Table 17. Major Manufacturers of Bifidobacterium Table 18. Major Manufacturers of Others Table 19. Global Probiotics for Middle-aged and Elderly Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Probiotics for Middle-aged and Elderly Sales by Type (2021-2026) & (k units) Table 21. Global Probiotics for Middle-aged and Elderly Sales by Type (2027-2032) & (k units) Table 22. Global Probiotics for Middle-aged and Elderly Sales Market Share by Type (2021-2026) Table 23. Global Probiotics for Middle-aged and Elderly Sales Market Share by Type (2027-2032) Table 24. Global Probiotics for Middle-aged and Elderly Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Probiotics for Middle-aged and Elderly Revenue by Type (2021-2026) & (k units) Table 26. Global Probiotics for Middle-aged and Elderly Revenue by Type (2027-2032) & (k units) Table 27. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type (2021-2026) Table 28. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Supermarket Table 30. Major Manufacturers of Online Retail Table 31. Major Manufacturers of Others Table 32. Global Probiotics for Middle-aged and Elderly Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Probiotics for Middle-aged and Elderly Sales by Application (2021-2026) & (k units) Table 34. Global Probiotics for Middle-aged and Elderly Sales by Application (2027-2032) & (k units) Table 35. Global Probiotics for Middle-aged and Elderly Sales Market Share by Application (2021-2026) Table 36. Global Probiotics for Middle-aged and Elderly Sales Market Share by Application (2027-2032) Table 37. Global Probiotics for Middle-aged and Elderly Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Probiotics for Middle-aged and Elderly Revenue by Application (2021-2026) & (k units) Table 39. Global Probiotics for Middle-aged and Elderly Revenue by Application (2027-2032) & (k units) Table 40. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application (2021-2026) Table 41. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application (2027-2032) Table 42. Global Probiotics for Middle-aged and Elderly Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Probiotics for Middle-aged and Elderly Sales by Region (2021-2026) & (k units) Table 44. Global Probiotics for Middle-aged and Elderly Sales Market Share by Region (2021-2026) Table 45. Global Probiotics for Middle-aged and Elderly Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Probiotics for Middle-aged and Elderly Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Probiotics for Middle-aged and Elderly Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units) Table 49. North America Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units) Table 50. Europe Probiotics for Middle-aged and Elderly Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units) Table 52. Europe Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Probiotics for Middle-aged and Elderly Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Probiotics for Middle-aged and Elderly Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units) Table 59. Global Probiotics for Middle-aged and Elderly Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Probiotics for Middle-aged and Elderly Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Probiotics for Middle-aged and Elderly Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Region (2021-2026) Table 63. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Region (2027-2032) Table 64. DuPont(Danisco) Company Information Table 65. DuPont(Danisco) Business Overview Table 66. DuPont(Danisco) Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. DuPont(Danisco) Probiotics for Middle-aged and Elderly Product Portfolio Table 68. DuPont(Danisco) Recent Development Table 69. Chr. Hansen Company Information Table 70. Chr. Hansen Business Overview Table 71. Chr. Hansen Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Chr. Hansen Probiotics for Middle-aged and Elderly Product Portfolio Table 73. Chr. Hansen Recent Development Table 74. China-Biotics Company Information Table 75. China-Biotics Business Overview Table 76. China-Biotics Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. China-Biotics Probiotics for Middle-aged and Elderly Product Portfolio Table 78. China-Biotics Recent Development Table 79. Nestle Company Information Table 80. Nestle Business Overview Table 81. Nestle Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Nestle Probiotics for Middle-aged and Elderly Product Portfolio Table 83. Nestle Recent Development Table 84. Danone Company Information Table 85. Danone Business Overview Table 86. Danone Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Danone Probiotics for Middle-aged and Elderly Product Portfolio Table 88. Danone Recent Development Table 89. BioGaia Company Information Table 90. BioGaia Business Overview Table 91. BioGaia Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. BioGaia Probiotics for Middle-aged and Elderly Product Portfolio Table 93. BioGaia Recent Development Table 94. OMNi-BiOTiC Company Information Table 95. OMNi-BiOTiC Business Overview Table 96. OMNi-BiOTiC Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. OMNi-BiOTiC Probiotics for Middle-aged and Elderly Product Portfolio Table 98. OMNi-BiOTiC Recent Development Table 99. Glory Biotech Company Information Table 100. Glory Biotech Business Overview Table 101. Glory Biotech Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Glory Biotech Probiotics for Middle-aged and Elderly Product Portfolio Table 103. Glory Biotech Recent Development Table 104. Ganeden Company Information Table 105. Ganeden Business Overview Table 106. Ganeden Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Ganeden Probiotics for Middle-aged and Elderly Product Portfolio Table 108. Ganeden Recent Development Table 109. Morinaga Milk Industry Company Information Table 110. Morinaga Milk Industry Business Overview Table 111. Morinaga Milk Industry Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Morinaga Milk Industry Probiotics for Middle-aged and Elderly Product Portfolio Table 113. Morinaga Milk Industry Recent Development Table 114. Sabinsa Company Information Table 115. Sabinsa Business Overview Table 116. Sabinsa Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Sabinsa Probiotics for Middle-aged and Elderly Product Portfolio Table 118. Sabinsa Recent Development Table 119. Greentech Company Information Table 120. Greentech Business Overview Table 121. Greentech Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Greentech Probiotics for Middle-aged and Elderly Product Portfolio Table 123. Greentech Recent Development Table 124. Bioriginal Company Information Table 125. Bioriginal Business Overview Table 126. Bioriginal Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Bioriginal Probiotics for Middle-aged and Elderly Product Portfolio Table 128. Bioriginal Recent Development Table 129. Biosearch Life Company Information Table 130. Biosearch Life Business Overview Table 131. Biosearch Life Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Biosearch Life Probiotics for Middle-aged and Elderly Product Portfolio Table 133. Biosearch Life Recent Development Table 134. UAS Laboratories Company Information Table 135. UAS Laboratories Business Overview Table 136. UAS Laboratories Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. UAS Laboratories Probiotics for Middle-aged and Elderly Product Portfolio Table 138. UAS Laboratories Recent Development Table 139. Synbiotech Company Information Table 140. Synbiotech Business Overview Table 141. Synbiotech Probiotics for Middle-aged and Elderly Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Synbiotech Probiotics for Middle-aged and Elderly Product Portfolio Table 143. Synbiotech Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Probiotics for Middle-aged and Elderly Distributors List Table 147. Probiotics for Middle-aged and Elderly Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Probiotics for Middle-aged and Elderly Product Image Figure 2. Global Probiotics for Middle-aged and Elderly Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Probiotics for Middle-aged and Elderly Market Size (2021-2032) & (US$ Million) Figure 4. Global Probiotics for Middle-aged and Elderly Sales (2021-2032) & (k units) Figure 5. Global Probiotics for Middle-aged and Elderly Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Probiotics for Middle-aged and Elderly Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Lactic Acid Bacteria Image Figure 9. Bifidobacterium Image Figure 10. Others Image Figure 11. Global Probiotics for Middle-aged and Elderly Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Probiotics for Middle-aged and Elderly Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Probiotics for Middle-aged and Elderly Sales Market Share by Type (2021-2032) Figure 14. Global Probiotics for Middle-aged and Elderly Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Probiotics for Middle-aged and Elderly Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type (2021-2032) Figure 17. Supermarket Image Figure 18. Online Retail Image Figure 19. Others Image Figure 20. Global Probiotics for Middle-aged and Elderly Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Probiotics for Middle-aged and Elderly Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Probiotics for Middle-aged and Elderly Sales Market Share by Application (2021-2032) Figure 23. Global Probiotics for Middle-aged and Elderly Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Probiotics for Middle-aged and Elderly Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application (2021-2032) Figure 26. North America Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Probiotics for Middle-aged and Elderly Sales Market Share by Country (2021-2032) Figure 28. U.S. Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Probiotics for Middle-aged and Elderly Sales Market Share by Country (2021-2032) Figure 33. Germany Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Probiotics for Middle-aged and Elderly Sales Market Share by Country (2021-2032) Figure 40. China Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Probiotics for Middle-aged and Elderly Sales Market Share by Country (2021-2032) Figure 48. Brazil Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Probiotics for Middle-aged and Elderly Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Probiotics for Middle-aged and Elderly Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Figure 59. North America Probiotics for Middle-aged and Elderly Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Figure 61. Europe Probiotics for Middle-aged and Elderly Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Probiotics for Middle-aged and Elderly Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Probiotics for Middle-aged and Elderly Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Probiotics for Middle-aged and Elderly Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Probiotics for Middle-aged and Elderly Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Lactic Acid Bacteria
  • Bifidobacterium
  • Others
Applications
  • Supermarket
  • Online Retail
  • Others
Companies covered
  • DuPont(Danisco)
  • Chr. Hansen
  • China-Biotics
  • Nestle
  • Danone
  • BioGaia
  • OMNi-BiOTiC
  • Glory Biotech
  • Ganeden
  • Morinaga Milk Industry
  • Sabinsa
  • Greentech
  • Bioriginal
  • Biosearch Life
  • UAS Laboratories
  • Synbiotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Probiotics for Middle-aged and Elderly Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Probiotics for Middle-aged and Elderly Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Probiotics for Middle-aged and Elderly Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Probiotics for Middle-aged and Elderly Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Probiotics for Middle-aged and Elderly Market Dynamics
  1. 2.1 Probiotics for Middle-aged and Elderly Industry Trends
  2. 2.2 Probiotics for Middle-aged and Elderly Industry Drivers
  3. 2.3 Probiotics for Middle-aged and Elderly Industry Opportunities and Challenges
  4. 2.4 Probiotics for Middle-aged and Elderly Industry Restraints
3 Probiotics for Middle-aged and Elderly Market by Manufacturers
  1. 3.1 Global Probiotics for Middle-aged and Elderly Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Probiotics for Middle-aged and Elderly Sales by Manufacturers (2021-2026)
  3. 3.3 Global Probiotics for Middle-aged and Elderly Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Probiotics for Middle-aged and Elderly Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Probiotics for Middle-aged and Elderly Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Probiotics for Middle-aged and Elderly Manufacturers, Product Type & Application
  7. 3.7 Global Probiotics for Middle-aged and Elderly Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Probiotics for Middle-aged and Elderly Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Probiotics for Middle-aged and Elderly Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Probiotics for Middle-aged and Elderly Tier 1, Tier 2, and Tier 3
4 Probiotics for Middle-aged and Elderly Market by Type
  1. 4.1 Probiotics for Middle-aged and Elderly Type Introduction
  2. 4.1.1 Lactic Acid Bacteria
  3. 4.1.2 Bifidobacterium
  4. 4.1.3 Others
  5. 4.2 Global Probiotics for Middle-aged and Elderly Sales by Type
  6. 4.2.1 Global Probiotics for Middle-aged and Elderly Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Probiotics for Middle-aged and Elderly Sales by Type (2021-2032)
  8. 4.2.3 Global Probiotics for Middle-aged and Elderly Sales Market Share by Type (2021-2032)
  9. 4.3 Global Probiotics for Middle-aged and Elderly Revenue by Type
  10. 4.3.1 Global Probiotics for Middle-aged and Elderly Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Probiotics for Middle-aged and Elderly Revenue by Type (2021-2032)
  12. 4.3.3 Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type (2021-2032)
5 Probiotics for Middle-aged and Elderly Market by Application
  1. 5.1 Probiotics for Middle-aged and Elderly Application Introduction
  2. 5.1.1 Supermarket
  3. 5.1.2 Online Retail
  4. 5.1.3 Others
  5. 5.2 Global Probiotics for Middle-aged and Elderly Sales by Application
  6. 5.2.1 Global Probiotics for Middle-aged and Elderly Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Probiotics for Middle-aged and Elderly Sales by Application (2021-2032)
  8. 5.2.3 Global Probiotics for Middle-aged and Elderly Sales Market Share by Application (2021-2032)
  9. 5.3 Global Probiotics for Middle-aged and Elderly Revenue by Application
  10. 5.3.1 Global Probiotics for Middle-aged and Elderly Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Probiotics for Middle-aged and Elderly Revenue by Application (2021-2032)
  12. 5.3.3 Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application (2021-2032)
6 Global Probiotics for Middle-aged and Elderly Sales by Region
  1. 6.1 Global Probiotics for Middle-aged and Elderly Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Probiotics for Middle-aged and Elderly Sales by Region (2021-2032)
  3. 6.2.1 Global Probiotics for Middle-aged and Elderly Sales by Region (2021-2026)
  4. 6.2.2 Global Probiotics for Middle-aged and Elderly Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Probiotics for Middle-aged and Elderly Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Probiotics for Middle-aged and Elderly Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Probiotics for Middle-aged and Elderly Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Probiotics for Middle-aged and Elderly Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Probiotics for Middle-aged and Elderly Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Probiotics for Middle-aged and Elderly Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Probiotics for Middle-aged and Elderly Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Probiotics for Middle-aged and Elderly Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Probiotics for Middle-aged and Elderly Revenue by Region
  1. 7.1 Global Probiotics for Middle-aged and Elderly Revenue by Region
  2. 7.1.1 Global Probiotics for Middle-aged and Elderly Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Probiotics for Middle-aged and Elderly Revenue by Region (2021-2026)
  4. 7.1.3 Global Probiotics for Middle-aged and Elderly Revenue by Region (2027-2032)
  5. 7.1.4 Global Probiotics for Middle-aged and Elderly Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Probiotics for Middle-aged and Elderly Revenue (2021-2032)
  8. 7.2.2 North America Probiotics for Middle-aged and Elderly Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Probiotics for Middle-aged and Elderly Revenue (2021-2032)
  11. 7.3.2 Europe Probiotics for Middle-aged and Elderly Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Probiotics for Middle-aged and Elderly Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Probiotics for Middle-aged and Elderly Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Probiotics for Middle-aged and Elderly Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Probiotics for Middle-aged and Elderly Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 DuPont(Danisco)
  2. 8.1.1 DuPont(Danisco) Company Information
  3. 8.1.2 DuPont(Danisco) Business Overview
  4. 8.1.3 DuPont(Danisco) Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 DuPont(Danisco) Probiotics for Middle-aged and Elderly Product Portfolio
  6. 8.1.5 DuPont(Danisco) Recent Developments
  7. 8.2 Chr. Hansen
  8. 8.2.1 Chr. Hansen Company Information
  9. 8.2.2 Chr. Hansen Business Overview
  10. 8.2.3 Chr. Hansen Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Chr. Hansen Probiotics for Middle-aged and Elderly Product Portfolio
  12. 8.2.5 Chr. Hansen Recent Developments
  13. 8.3 China-Biotics
  14. 8.3.1 China-Biotics Company Information
  15. 8.3.2 China-Biotics Business Overview
  16. 8.3.3 China-Biotics Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 China-Biotics Probiotics for Middle-aged and Elderly Product Portfolio
  18. 8.3.5 China-Biotics Recent Developments
  19. 8.4 Nestle
  20. 8.4.1 Nestle Company Information
  21. 8.4.2 Nestle Business Overview
  22. 8.4.3 Nestle Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nestle Probiotics for Middle-aged and Elderly Product Portfolio
  24. 8.4.5 Nestle Recent Developments
  25. 8.5 Danone
  26. 8.5.1 Danone Company Information
  27. 8.5.2 Danone Business Overview
  28. 8.5.3 Danone Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Danone Probiotics for Middle-aged and Elderly Product Portfolio
  30. 8.5.5 Danone Recent Developments
  31. 8.6 BioGaia
  32. 8.6.1 BioGaia Company Information
  33. 8.6.2 BioGaia Business Overview
  34. 8.6.3 BioGaia Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BioGaia Probiotics for Middle-aged and Elderly Product Portfolio
  36. 8.6.5 BioGaia Recent Developments
  37. 8.7 OMNi-BiOTiC
  38. 8.7.1 OMNi-BiOTiC Company Information
  39. 8.7.2 OMNi-BiOTiC Business Overview
  40. 8.7.3 OMNi-BiOTiC Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 OMNi-BiOTiC Probiotics for Middle-aged and Elderly Product Portfolio
  42. 8.7.5 OMNi-BiOTiC Recent Developments
  43. 8.8 Glory Biotech
  44. 8.8.1 Glory Biotech Company Information
  45. 8.8.2 Glory Biotech Business Overview
  46. 8.8.3 Glory Biotech Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Glory Biotech Probiotics for Middle-aged and Elderly Product Portfolio
  48. 8.8.5 Glory Biotech Recent Developments
  49. 8.9 Ganeden
  50. 8.9.1 Ganeden Company Information
  51. 8.9.2 Ganeden Business Overview
  52. 8.9.3 Ganeden Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ganeden Probiotics for Middle-aged and Elderly Product Portfolio
  54. 8.9.5 Ganeden Recent Developments
  55. 8.10 Morinaga Milk Industry
  56. 8.10.1 Morinaga Milk Industry Company Information
  57. 8.10.2 Morinaga Milk Industry Business Overview
  58. 8.10.3 Morinaga Milk Industry Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Morinaga Milk Industry Probiotics for Middle-aged and Elderly Product Portfolio
  60. 8.10.5 Morinaga Milk Industry Recent Developments
  61. 8.11 Sabinsa
  62. 8.11.1 Sabinsa Company Information
  63. 8.11.2 Sabinsa Business Overview
  64. 8.11.3 Sabinsa Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sabinsa Probiotics for Middle-aged and Elderly Product Portfolio
  66. 8.11.5 Sabinsa Recent Developments
  67. 8.12 Greentech
  68. 8.12.1 Greentech Company Information
  69. 8.12.2 Greentech Business Overview
  70. 8.12.3 Greentech Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Greentech Probiotics for Middle-aged and Elderly Product Portfolio
  72. 8.12.5 Greentech Recent Developments
  73. 8.13 Bioriginal
  74. 8.13.1 Bioriginal Company Information
  75. 8.13.2 Bioriginal Business Overview
  76. 8.13.3 Bioriginal Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bioriginal Probiotics for Middle-aged and Elderly Product Portfolio
  78. 8.13.5 Bioriginal Recent Developments
  79. 8.14 Biosearch Life
  80. 8.14.1 Biosearch Life Company Information
  81. 8.14.2 Biosearch Life Business Overview
  82. 8.14.3 Biosearch Life Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biosearch Life Probiotics for Middle-aged and Elderly Product Portfolio
  84. 8.14.5 Biosearch Life Recent Developments
  85. 8.15 UAS Laboratories
  86. 8.15.1 UAS Laboratories Company Information
  87. 8.15.2 UAS Laboratories Business Overview
  88. 8.15.3 UAS Laboratories Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 UAS Laboratories Probiotics for Middle-aged and Elderly Product Portfolio
  90. 8.15.5 UAS Laboratories Recent Developments
  91. 8.16 Synbiotech
  92. 8.16.1 Synbiotech Company Information
  93. 8.16.2 Synbiotech Business Overview
  94. 8.16.3 Synbiotech Probiotics for Middle-aged and Elderly Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Synbiotech Probiotics for Middle-aged and Elderly Product Portfolio
  96. 8.16.5 Synbiotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Probiotics for Middle-aged and Elderly Value Chain Analysis
  2. 9.1.1 Probiotics for Middle-aged and Elderly Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Probiotics for Middle-aged and Elderly Production Mode & Process
  6. 9.2 Probiotics for Middle-aged and Elderly Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Probiotics for Middle-aged and Elderly Distributors
  9. 9.2.3 Probiotics for Middle-aged and Elderly Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research